These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578 [TBL] [Abstract][Full Text] [Related]
7. Keeping each other in check: a reciprocal relationship between cytokines and miRNA. Andersen MH Cell Cycle; 2013 Jul; 12(14):2171. PubMed ID: 23803727 [No Abstract] [Full Text] [Related]
8. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Ehrentraut S; Schneider B; Nagel S; Pommerenke C; Quentmeier H; Geffers R; Feist M; Kaufmann M; Meyer C; Kadin ME; Drexler HG; MacLeod RA Oncotarget; 2016 Jun; 7(23):34201-16. PubMed ID: 27144517 [TBL] [Abstract][Full Text] [Related]
9. miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway. Xia L; Wu L; Xia H; Bao J; Li Q; Chen X; Xia R Cell Cycle; 2019 Jul; 18(14):1635-1645. PubMed ID: 31213131 [TBL] [Abstract][Full Text] [Related]
10. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway. Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009 [TBL] [Abstract][Full Text] [Related]
11. Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma. Lauenborg B; Christensen L; Ralfkiaer U; Kopp KL; Jønson L; Dabelsteen S; Bonefeld CM; Geisler C; Gjerdrum LM; Zhang Q; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A Oncotarget; 2015 Jun; 6(17):15235-49. PubMed ID: 25915535 [TBL] [Abstract][Full Text] [Related]
13. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169 [TBL] [Abstract][Full Text] [Related]
14. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Abraham RM; Zhang Q; Odum N; Wasik MA Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma. Shen X; Wang B; Li K; Wang L; Zhao X; Xue F; Shi R; Zheng J J Invest Dermatol; 2018 Sep; 138(9):2024-2032. PubMed ID: 29559342 [TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients. Bagdonaite I; Wandall HH; Litvinov IV; Nastasi C; Becker JC; Dabelsteen S; Geisler C; Bonefeld CM; Zhang Q; Wasik MA; Zhou Y; Sasseville D; Ødum N; Woetmann A Oncotarget; 2015 Jun; 6(16):14374-84. PubMed ID: 25957418 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Geskin LJ; Viragova S; Stolz DB; Fuschiotti P Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470 [TBL] [Abstract][Full Text] [Related]
19. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma. Yumeen S; Girardi M Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341 [TBL] [Abstract][Full Text] [Related]